KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Other Accumulated Expenses: 2009-2025

Historic Other Accumulated Expenses for Encompass Health (EHC) over the last 17 years, with Q3 2025 value amounting to $558.7 million.

  • Encompass Health's Other Accumulated Expenses rose 1948.25% to $558.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $558.7 million, marking a year-over-year increase of 1948.25%. This contributed to the annual value of $505.1 million for FY2024, which is 16953.04% up from last year.
  • Latest data reveals that Encompass Health reported Other Accumulated Expenses of $558.7 million as of Q3 2025, which was up 1948.25% from $525.9 million recorded in Q2 2025.
  • Encompass Health's Other Accumulated Expenses' 5-year high stood at $611.2 million during Q2 2022, with a 5-year trough of $177.3 million in Q4 2021.
  • Its 5-year average for Other Accumulated Expenses is $443.8 million, with a median of $471.2 million in 2024.
  • Per our database at Business Quant, Encompass Health's Other Accumulated Expenses tumbled by 3190.45% in 2023 and then soared by 16953.04% in 2024.
  • Quarter analysis of 5 years shows Encompass Health's Other Accumulated Expenses stood at $177.3 million in 2021, then grew by 2.14% to $181.1 million in 2022, then grew by 3.48% to $187.4 million in 2023, then surged by 169.53% to $505.1 million in 2024, then increased by 10.61% to $558.7 million in 2025.
  • Its Other Accumulated Expenses stands at $558.7 million for Q3 2025, versus $525.9 million for Q2 2025 and $531.5 million for Q1 2025.